ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DERRICK NGUYEN MD

Internal Medicine

717

$257K

69
50 are 65+

25%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 27%

$358
Average prescription price

Avg: $67

JOSHUA GOLD M.D.

Internal Medicine

715

$68.7K

58
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$96
Average prescription price

Avg: $67

JAMAL LONE M.D.

Internal Medicine

713

$35.1K

219
179 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

42%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

GAVIN MELMED MD

Internal Medicine

712

$306K

92
78 are 65+

21%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 27%

$430
Average prescription price

Avg: $67

SILVIA DIDIA M.D.

Internal Medicine

710

$49.2K

223
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $67

KHAWER KHADIMALLY DO

Internal Medicine

710

$41.1K

90
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

ROY VARUGHESE M.D.

Internal Medicine

707

$40.2K

130
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

29%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

HAROLD SZERLIP MD

Internal Medicine

707

$27.7K

92
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$39
Average prescription price

Avg: $67

LINSHENG GUO M.D.

Internal Medicine

704

$186K

99
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 27%

$264
Average prescription price

Avg: $67

JOHN DARAMOLA MD

Internal Medicine

702

$33.1K

189
139 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

WILLIAM NOVELLI MD, MPH

Internal Medicine

702

$66K

41
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

39%
patients receiving schedule three controlled substances

Avg: 15%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$94
Average prescription price

Avg: $67

KENDRA BELFI M.D.

Internal Medicine

700

$50.2K

86
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

JOSHUA EVANS D.O.

Internal Medicine

699

$41.4K

116
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$59
Average prescription price

Avg: $67

JOSE SOTO M.D.

Internal Medicine

698

$38.8K

47
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

JOSE BURGOS M.D.

Internal Medicine

697

$37.3K

150
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

STEVEN MORALEZ M.D.

Internal Medicine

697

$42.7K

133
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

CHANDRA ANNAPUREDDY M.D.

Internal Medicine

693

$33.4K

197
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

LARA COLTON MD

Internal Medicine

692

$39K

96
61 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

SCOTT BARTELS M.D.

Internal Medicine

691

$80.5K

86
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 27%

$116
Average prescription price

Avg: $67

VENKATA SAMAVEDI MD

Internal Medicine

688

$42.7K

37
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $67

RASHID KHAN MD

Internal Medicine

685

$145K

109
39 are 65+

31%
patients receiving schedule two controlled substances

Avg: 1%

50%
patients receiving schedule three controlled substances

Avg: 15%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$211
Average prescription price

Avg: $67

RAJESHWAR KUMAR MD

Internal Medicine

681

$41K

34
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

JOSEPH RAVENELL MD

Internal Medicine

678

$45K

89
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

PHILBERT YAU M.D.

Internal Medicine

677

$39.2K

81
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 15%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 27%

$58
Average prescription price

Avg: $67

STEPHEN RICHEY M.D., M.P.H

Internal Medicine

676

$237K

105
88 are 65+

29%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 27%

$350
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank